Patent RDF

• Device and method for delivering therapeutic substances to the maxillary sinus of a patient
• Lipid growth factor formulations
• Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage
• Method of treating Parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
• Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
• Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
• Treatment of hypoglycemia unawareness with intranasal insulin